Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYT004-MelQbG10 in Stage III/IV Malignant Melanoma
NCT00651703Phase 2Completed
- Sponsor
- Cytos Biotechnology AG
- Start
- Apr 2008
- Primary completion
- Dec 2009
- Countries
- 1
01
Overview
A Phase 2 trial of CYT004-MelQbG10 in Malignant Melanoma (MM), sponsored by Cytos Biotechnology AG. Started Apr 2008; status: completed.
02
Drugs
CYT004-MelQbG10
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT00651703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00651703.